tenmzSign inSign up free

Growth rankings

Sorted from public revenue and financial data: the latest fully reported month of revenue, or the latest quarter EPS against the same quarter last year. This is data, not a recommendation.

Revenue month:2026-09|1427 stocks|revenue of at least NT$100M

RankStockRevenue (NT$100M)YoYMoMYTD YoY
1213450 聯鈞12.89+99.78%+3.31%+36.47%
1226227 茂綸23.56+99.51%-33.46%+55.60%
1232636 台驊控股29.96+99.17%+3.00%+25.53%
1242432 倚天酷碁-創6.75+98.88%+51.93%+66.27%
1256547 高端疫苗2.07+98.84%-12.35%+52.72%
1268021 尖點8.3+98.33%+7.65%+79.11%
1278422 可寧衛*7.09+97.80%+1.13%+41.74%
1284979 華星光5.75+97.78%+5.30%+27.29%
1293443 創意71.45+97.78%+22.35%+102.83%
1302615 萬海217.75+97.63%+13.41%+27.28%
1312460 建通4.81+97.55%+9.84%+68.80%
1326811 宏碁資訊15.3+97.40%+30.74%+33.45%
1336442 光聖20.61+97.26%+26.59%+50.19%
1341312 國喬41.55+96.81%+74.50%+30.29%
1352348 海悅14.81+96.30%+3.93%+83.29%
1363416 融程電5.35+95.91%+31.78%+34.24%
1376770 力積電76.65+93.95%+9.36%+52.49%
1384903 聯光通2.81+93.83%+300.97%+22.28%
1394949 有成精密3.94+93.29%+27.00%+57.87%
1406667 信紘科11.75+91.53%+46.59%+21.19%
1416863 永道-KY5.97+90.72%+35.64%+48.35%
1422467 志聖9.45+90.65%+9.16%+84.20%
1433209 全科57.03+90.48%+6.16%+46.69%
1446531 愛普*11.89+90.15%+15.31%+105.99%
1454142 國光生3.1+90.14%+216.13%+31.81%
1463703 欣陸43.05+89.32%+75.47%+3.45%
1473706 神達189.13+88.65%+39.50%+57.39%
1486196 帆宣71.74+88.49%-0.63%+55.51%
1496515 穎崴12.5+87.72%-26.69%+96.67%
1506163 華電網9.17+87.35%+100.41%+34.73%

tenmz is an investment education and personal analysis tool. It is not a licensed securities investment consulting enterprise in Taiwan and does not recommend any security or provide buy or sell advice. Data is for learning and reference only and may be delayed, incomplete or inaccurate; official announcements by the Taiwan Stock Exchange, the Taipei Exchange and the Market Observation Post System prevail. You are solely responsible for your own investment decisions. Investing involves risk, including the loss of principal. In case of any discrepancy, the Chinese version of these terms prevails.